MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4.

Zheng, Rui-Peng; Ma, Dong-Kai; Li, Zhuo; Zhang, Hai-Feng

Zheng, Rui-Peng; Ma, Dong-Kai; Li, Zhuo; Zhang, Hai-Feng.

Afiliação

Zheng RP; Department of Interventional Therapy, The First Hospital of Jilin University, Changchun, Jilin Province 130021, People's Republic of China.
Ma DK; Department of Gastroenterology and Hepatology, Qian Wei Hospital of Jilin Province, Changchun, Jilin Province 130012, People's Republic of China.
Li Z; Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin Province 130021, People's Republic of China.
Zhang HF; Department of Interventional Therapy, The First Hospital of Jilin University, Changchun, Jilin Province 130021, People's Republic of China.

Cancer Manag Res ; 12: 6165-6175, 2020.

Article em En | MEDLINE | ID: mdl-32801865

Palavras-chave

5-fluorouracil; TLR4; drug resistance; hepatic carcinoma; miR-145; toll-like receptor 4

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Manag Res Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google